RightFit Trial Directory

Leukemia clinical trials in Rochester, MN

18 recruiting leukemia studies with a site in Rochester, MN.

All trials in Rochester, MN · All Leukemia trials

RecruitingPhase 3NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Sponsor: Alliance for Clinical Trials in Oncology

Aitkin, MN · Brainerd, MN · Burnsville, MN · +452 more sites

RecruitingPhase not listedNCT07143669

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Sponsor: Blueprint Medicines Corporation

Rochester, MN · +24 more sites

RecruitingPhase 1NCT05091424

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Sponsor: Hoffmann-La Roche

Rochester, MN · +4 more sites

RecruitingPhase 2NCT03516617

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Sponsor: Mayo Clinic

Rochester, MN · +2 more sites

RecruitingPhase 3NCT07277231

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Sponsor: BeOne Medicines

Rochester, MN · +21 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Minneapolis, MN · Rochester, MN · +183 more sites

RecruitingPhase 2 / Phase 3NCT03013998

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Sponsor: Beat AML, LLC

Rochester, MN · +30 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Minneapolis, MN · Rochester, MN · +161 more sites

RecruitingPhase not listedNCT02560883

Hairy Cell Leukemia Patient Data Registry

Sponsor: Ohio State University Comprehensive Cancer Center

Rochester, MN · +4 more sites

RecruitingPhase 1NCT05549661

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 1NCT03017820

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Sponsor: Mayo Clinic

Rochester, MN · +1 more sites

RecruitingPhase not listedNCT05978141

A Registry for People With T-cell Lymphoma

Sponsor: Memorial Sloan Kettering Cancer Center

Rochester, MN · +25 more sites

RecruitingPhase not listedNCT06279572

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Sponsor: Mayo Clinic

Rochester, MN · +2 more sites

RecruitingPhase not listedNCT06536452

Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 4NCT06876649

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Sponsor: Eli Lilly and Company

Rochester, MN · +19 more sites

RecruitingPhase not listedNCT06151730

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase not listedNCT06600659

A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 1NCT06712810

Q702 for the Treatment of Patients With Hematologic Malignancies

Sponsor: Mayo Clinic

Rochester, MN · +1 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.